日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Shewanella oneidensis Deoxyguanosinetriphosphate triphosphohydrolase-like protein (SO_2485) CSB-YP815026SGA
CSB-EP815026SGA
CSB-BP815026SGA
CSB-MP815026SGA
CSB-EP815026SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis tRNA (mo5U34)-methyltransferase (cmoB) CSB-YP815027SGA
CSB-EP815027SGA
CSB-BP815027SGA
CSB-MP815027SGA
CSB-EP815027SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Cytidylate kinase (cmk) CSB-YP815028SGA
CSB-EP815028SGA
CSB-BP815028SGA
CSB-MP815028SGA
CSB-EP815028SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Negative modulator of initiation of replication (seqA) CSB-YP815029SGA
CSB-EP815029SGA
CSB-BP815029SGA
CSB-MP815029SGA
CSB-EP815029SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Protein CrcB homolog (crcB), partial CSB-YP815030SGA1
CSB-EP815030SGA1
CSB-BP815030SGA1
CSB-MP815030SGA1
CSB-EP815030SGA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Threonine--tRNA ligase (thrS), partial CSB-YP815031SGA
CSB-EP815031SGA
CSB-BP815031SGA
CSB-MP815031SGA
CSB-EP815031SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Co-chaperone protein hscB homolog (hscB) CSB-YP815032SGA
CSB-EP815032SGA
CSB-BP815032SGA
CSB-MP815032SGA
CSB-EP815032SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Uncharacterized transporter SO_2143 (SO_2143), partial CSB-YP815033SGA
CSB-EP815033SGA
CSB-BP815033SGA
CSB-MP815033SGA
CSB-EP815033SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Phenylalanine--tRNA ligase beta subunit (pheT), partial CSB-YP815034SGA
CSB-EP815034SGA
CSB-BP815034SGA
CSB-MP815034SGA
CSB-EP815034SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Ferrochelatase 1 (hemH1) CSB-YP815035SGA
CSB-EP815035SGA
CSB-BP815035SGA
CSB-MP815035SGA
CSB-EP815035SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis NAD-dependent protein deacylase (cobB) CSB-YP815036SGA
CSB-EP815036SGA
CSB-BP815036SGA
CSB-MP815036SGA
CSB-EP815036SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis UPF0319 protein SO_1816 (SO_1816) CSB-YP815037SGA
CSB-EP815037SGA
CSB-BP815037SGA
CSB-MP815037SGA
CSB-EP815037SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Bifunctional protein FolD (folD) CSB-YP815038SGA
CSB-EP815038SGA
CSB-BP815038SGA
CSB-MP815038SGA
CSB-EP815038SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Homoserine O-succinyltransferase (metA) CSB-YP815039SGA
CSB-EP815039SGA
CSB-BP815039SGA
CSB-MP815039SGA
CSB-EP815039SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Uridylate kinase (pyrH) CSB-YP815040SGA
CSB-EP815040SGA
CSB-BP815040SGA
CSB-MP815040SGA
CSB-EP815040SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Protein Xni (xni) CSB-YP815041SGA
CSB-EP815041SGA
CSB-BP815041SGA
CSB-MP815041SGA
CSB-EP815041SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis T-protein (tyrA) CSB-YP815042SGA
CSB-EP815042SGA
CSB-BP815042SGA
CSB-MP815042SGA
CSB-EP815042SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Thymidylate synthase (thyA) CSB-YP815043SGA
CSB-EP815043SGA
CSB-BP815043SGA
CSB-MP815043SGA
CSB-EP815043SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Aquaporin Z (aqpZ), partial CSB-YP815044SGA1
CSB-EP815044SGA1
CSB-BP815044SGA1
CSB-MP815044SGA1
CSB-EP815044SGA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Shewanella oneidensis Deoxyribose-phosphate aldolase (deoC) CSB-YP815045SGA
CSB-EP815045SGA
CSB-BP815045SGA
CSB-MP815045SGA
CSB-EP815045SGA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×